17. Multiple system atrophy Clinical trials / Disease details

Clinical trials : 118 / Drugs : 163 - (DrugBank : 49) / Drug target genes : 61 - Drug target pathways : 112

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2018-004145-16-IT (EUCTR)	05/09/2019	21/01/2021	A study evaluating the safety and efficacy of safinamide for patients with Multiple System Atrophy	A 12-weeks, multicentre, randomized, double-blind, placebo-controlled, exploratory, pilot study to e ...	Parkinsonian variant of Multiple System Atrophy MedDRA version: 21.1;Level: PT;Classification code 1 ...	Trade Name: Xadago Product Name: Xadago Product Code: [Z7219] INN or Proposed INN: SAFINAMIDE METANSOLFO ...	ZAMBON SPA	NULL	Not Recruiting			Female: yes Male: yes	48	Phase 2	Spain;Italy
2	EUCTR2018-004145-16-ES (EUCTR)	24/07/2019	11/06/2019	A study evaluating the safety and efficacy of safinamide for patients with Multiple System Atrophy	A 12-weeks, multicentre, randomized, double-blind, placebo-controlled, exploratory, pilot study to e ...	Parkinsonian variant of Multiple System Atrophy MedDRA version: 20.0;Level: PT;Classification code 1 ...	Trade Name: Xadago INN or Proposed INN: safinamide methanesulfonate Other descriptive name: SAFINAMIDE	Zambon SpA	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	48	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): yes Therapeutic confirmatory - ( ...	Spain

First Previous1Next Last